Star Refrigeration relocates Oxford branch to Reading to service growing customer base

The central and better-connected location brings the company closer to its customers to foster stronger relationships and enhance customer excellence. Star Refrigeration are delighted to announce the relocation of their Oxford branch to new premises at Unit G, Lambs Farm Business Park in Reading, as business demand continues to grow in the South East region. […]

Star Refrigeration relocates Oxford branch to Reading to service growing customer base

The central and better-connected location brings the company closer to its customers to foster stronger relationships and enhance customer excellence. Star Refrigeration are delighted to announce the relocation of their Oxford branch to new premises at Unit G, Lambs Farm Business Park in Reading, as business demand continues to grow in the South East region.

Advantest’s VOICE 2025 Draws Record Attendance in Austin, Texas

Advantest's VOICE 2025 Draws Record Attendance in Austin, Texas Annual Developer Conference Hosts Major Semiconductor Companies for Dialogue on Latest Test Technologies and Industry Trends GlobeNewswire July 02, 2025 TOKYO, July 02, 2025 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) concluded a successful VOICE 2025 at the AT&T Conference Center

Premier Roofing LLC Sets the Standard for Quality and Innovation in the Roofing Industry

Meredith, NH – Premier Roofing LLC continues to lead the roofing industry with its proven combination of experience, innovation, and customer-focused services. With over two decades of hands-on experience, the company has established itself as a dependable provider of residential and commercial roofing solutions, recognized for its commitment to long-term quality and environmentally responsible practices.

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

(NASDAQ:BLTE), – 500 subjects enrolled across the United States, the United Kingdom, France, Czech Republic, Switzerland, China, Taiwan, and Australia SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced

Turntide Technologies Secures Hitachi Order to Power the First Battery Trains Built in the UK

Gateshead, U.K. and Atlanta, Georgia, July 02, 2025 (GLOBE NEWSWIRE) — Turntide Technologies, a global leader in electrification solutions, has been selected by Hitachi Rail to supply Gen 2 lithium iron phosphate (LFP) battery system for its Grand Central intercity battery train contract. Turntide Technologies will supply next-generation LFP batteries, which are designed to be

Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health

Funding supports market launch of platform for clinical and commercial applications Company targets Euro 15 billion in silico trials market and ICU decision support Munich, Germany – July 2, 2025 — Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that it has received

Leading global institutions launch alliance to advance human-centric urban research

Five globally respected academic institutions have come together to launch the Global Alliance on Sustainable Urban Societies – a pioneering initiative that places people at the heart of urban research and policymaking. The partnership was announced today at the Singapore Management University (SMU) City Dialogues held in Vienna, taking place as part of the Mayors

Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health

Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health GlobeNewswire July 02, 2025 Funding supports market launch of platform for clinical and commercial applications Company targets Euro 15 billion in silico trials market and ICU decision support Munich, Germany – July 2, 2025 — Ebenbuild, a company developing personalized,

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy GlobeNewswire July 02, 2025 – 500 subjects enrolled across the United States, the United Kingdom, France, Czech Republic, Switzerland, China, Taiwan, and Australia SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ:

Scroll to Top